Back to News
Market Impact: 0.6

US customs duties top $100 billion for first time in a fiscal year

TRI
Tax & TariffsFiscal Policy & BudgetEconomic DataTrade Policy & Supply ChainSovereign Debt & RatingsAnalyst Insights
US customs duties top $100 billion for first time in a fiscal year

U.S. customs duties surpassed $100 billion for the first time in a fiscal year, reaching $113.3 billion gross for the first nine months of FY2025, which significantly boosted federal revenue and contributed to a surprise $27 billion budget surplus in June. This surge, with June collections quadrupling to $27.2 billion, establishes tariffs as the federal government's fourth-largest revenue source, now comprising approximately 5% of total receipts. These robust collections reinforce the administration's tariff policy, with further duties on various imports set to take effect, signaling a continued reliance on tariffs as both a fiscal instrument and a foreign policy tool.

Analysis

U.S. customs duty collections have become a significant fiscal contributor, surpassing $100 billion for the first time in a fiscal year and driving a surprise $27 billion budget surplus for June. For the first nine months of fiscal 2025, net customs duties nearly doubled year-over-year to $108 billion, elevating tariffs to the fourth-largest federal revenue source at approximately 5% of total receipts, up from a historical 2%. This revenue surge, which saw June collections quadruple to $27.2 billion, is a direct outcome of the administration's aggressive tariff strategy. However, this headline surplus masks underlying fiscal challenges; the overall year-to-date deficit has widened by 5% to $1.337 trillion, driven by increased outlays on healthcare, defense, and debt interest, the latter costing $921 billion YTD. Furthermore, after adjusting for calendar shifts, the June surplus becomes a $70 billion deficit. The administration intends to escalate its tariff policy, with new levies on imports from Brazil and Canada, as well as on copper, semiconductors, and pharmaceuticals, set to begin on August 1. While this points to continued strong tariff revenue in the near term, experts caution that this income stream may prove unsustainable as businesses and consumers adjust behavior to mitigate costs over the long run.